| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer,Svp-r& D | Chief Scientific Officer,Svp-r& D | Sr Vp-research & Development +1 more
1 company
Frederique Ph.D. Menzaghi last filed a Form 4 in February 2024, as Chief Scientific Officer,Svp-r& D at TVRD. From March 2015 to February 2024, the filings on record show 0 open-market purchases and 45 sales. Frederique Ph.D. Menzaghi's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Frederique Ph.D. Menzaghi a strong insider score of 85/100, based on 7 past trades. Over a 12-month horizon, all 7 of those trades were profitable, with an average 12-month return of +64.8%.
At the last filing, the largest reported position was 167,247 shares of TVRD. The TVRD filings lean toward selling, a net 283,239 shares.
Shares as reported in the last Form 4 for each company; the most recent is from February 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 21, 2020 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Officer,Svp-r& D | Sell | 12,894 | $15.58 | $200,888.52 | -11.0% | |
| Oct 25, 2019 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Officer,Svp-r& D | Sell | 4,000 | $19.91 | $79,640.00 | -5.9% | |
| Oct 18, 2019 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Officer,Svp-r& D | Sell | 4,000 | $19.33 | $77,320.00 | -5.6% | |
| Oct 11, 2019 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Officer,Svp-r& D | Sell | 4,000 | $18.70 | $74,800.00 | -5.3% | |
| Oct 4, 2019 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Officer,Svp-r& D | Sell | 4,000 | $19.19 | $76,760.00 | -5.0% | |
| Sep 3, 2019 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Officer,Svp-r& D | Sell | 20,000 | $22.92 | $458,400.00 | -20.0% | |
| Aug 1, 2019 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Officer,Svp-r& D | Sell | 20,000 | $23.24 | $464,800.00 | -16.7% | |
| Jul 17, 2019 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Officer,Svp-r& D | Sell | 8,996 | $27.50 | $247,390.00 | -7.0% | |
| Jul 1, 2019 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Officer,Svp-r& D | Sell | 20,000 | $21.90 | $438,000.00 | -13.4% | |
| May 29, 2019 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Officer,Svp-r& D | Sell | 11,397 | $21.19 | $241,502.43 | -7.1% |